The shortfall of generic drugs, which comprise the majority of medications that Americans consume, has been a chronic problem, starting well before the mid-2020s.

AstraZeneca, one of 10 drugmakers that have drugs selected for the Medicare price negotiation program, has lost its suit challenging the program, while four more drugmaker lawsuits will be heard this week.

The Consumer Financial Protection Bureau's Director Rohit Chopra is making a sweeping change to address medical debt that now touches some 100 million Americans, and the new rules are expected to be unveiled later this year.

Aetna uses Change Healthcare as an intermediary for certain data exchanges, and many of its in-network providers use it to submit claims to Aetna, however, the insurer announced its systems have not been comprised.

On this episode of ShiftShapers, a podcast focused on the employee benefits industry, host David Saltzman discusses the secrets of business growth with Kevin Trokey and Wendy Keneipp from Q4 Intelligence.

Here are three post-renewal communication strategies that can prove that you are a vital partner who is committed to the success of your clients currently and into 2024.

Any prolonged disruption of the health care tech company's systems "will negatively impact many hospitals' ability to offer the full set of health-care services," wrote the American Hospital Association to HHS Secretary Xavier Becerra.

Two of the nation's largest pharmacy chains announced plans on Friday to begin selling mifepristone in states where abortion is legal, after receiving certification to dispense the pills following a FDA regulatory shift last year.